Efficacy of Hydrogen Peroxide Gel on Periodontitis With Diabetes
Launched by UNIVERSITY OF OKLAHOMA · Dec 19, 2022
Trial Information
Current as of June 18, 2025
Withdrawn
Keywords
ClinConnect Summary
The primary treatment for periodontitis is scaling and root planing (SRP), which refers to the mechanical disruption and removal of bacteria and bacterial toxins from the affected tooth root surfaces. This procedure predictably reduces the bacterial load and produces marked improvement in clinical periodontal parameters, though not always complete resolution of the disease. Periodontal therapy may have some systemic benefits by reducing entry into the systemic circulation of pro inflammatory molecules and bacterial byproducts from the periodontal tissues. Since SRP alone is not always a com...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults \>18 , \<80 year old with moderate to severe periodontitis as defined by the Word workshop criteria having Type II diabetes mellitus with HbA1 C levels of \>6.5%.
- • 2. No SRP within the past 6 months.
- • 3. Willingness to comply with study instructions and refrain from using oral hygiene products/ procedures outside the study.
- Exclusion Criteria:
- • The researcher believes that it is not in the patient's best interest to stay in the study
- • Based on the exclusion criteria, the patient becomes ineligible to participate
- • Patient's medical condition requires interventions which preclude involvement in the study
- • Patient does not follow study related instructions
- • The study is suspended or canceled
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
John Dmytryk, DDS, PhD
Study Chair
The University of Oklahoma, College of Dentistry, Division in Periodontics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials